A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis-Reference-Cited by-同舟云学术

A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis

Published:2016-09-09 Issue:12 Volume:18 Page:1411-1414
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Girerd Nicolas¹,Ferreira João Pedro¹²,Rossignol Patrick¹,Zannad Faiez¹

Affiliation:

1. INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116; Université de Lorraine; CHRU de Nancy, F-CRIN INI-CRCT Nancy France

2. Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine; University of Porto; Porto Portugal

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

2. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006

3. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry;Fonarow;J Am Coll Cardiol,2007

4. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme;McMurray;Eur J Heart Fail,2003

5. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM;Lewis;Eur J Heart Fail,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment;Clinical Research in Cardiology;2024-04-11

2. The current best drug treatment for hypertensive heart failure with preserved ejection fraction;European Journal of Internal Medicine;2024-02

3. What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence;American Journal of Hypertension;2023-08-08

4. The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction;Cardiovascular Diabetology;2023-06-29

5. Novidades e Reflexões sobre o Tratamento Farmacológico da Insuficiência Cardíaca com Fração de Ejeção Preservada;Arquivos Brasileiros de Cardiologia;2022-09-06